Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 19 - Drugs for skeletal disorders
Patents for A61P 19 - Drugs for skeletal disorders (81,981)
12/2010
12/15/2010CN101006999B Therapeutic uses and compositions of isoflavones
12/14/2010US7851635 which comprises thiadiazoline derivatives, effective in treatment of a disease associated with cell proliferation, such as restenosis, cardiac hypertrophy and immunologic diseases
12/14/2010US7851594 Human cytokine receptor
12/14/2010US7851458 Cartilage enhancing food supplements and methods of preparing the same
12/14/2010US7851171 Using actinobacillus specific immunogolbulins to diagnose gum disease
12/14/2010US7850968 Cluster of differentiation 83 specific immunoglobulin for use in treatment of autoimmune and neoplastic disorders
12/14/2010US7850963 Vascular endothelial growth factor 2
12/14/2010CA2485641C Novel condensed imidazole derivatives
12/14/2010CA2470044C Pyrrolopyrimidine a2b selective antagonist compounds, their synthesis and use
12/14/2010CA2437944C Acylated indanyl amines and their use as pharmaceuticals
12/14/2010CA2412723C Benzothiazolyl ppar-gamma modulators
12/14/2010CA2373433C Spiroimidazolidine derivatives, their preparation, their use and pharmaceutical preparations comprising them
12/14/2010CA2366857C Phthalazine derivatives for treating inflammatory diseases
12/09/2010WO2010141845A2 Immunoregulatory peptides and methods of use
12/09/2010WO2010141824A2 Use of targeted nitroxide agents in bone healing
12/09/2010WO2010141817A1 Heteroaryl-substituted spirocyclic diamine urea modulators of fatty acid amide hydrolase
12/09/2010WO2010140986A1 Targetted drug delivery to the bone
12/09/2010WO2010140377A1 Vaccine for mycoplasma infection
12/09/2010WO2010139690A1 Bacteria thya(-) mutants with increased vitamin k
12/09/2010WO2010124276A9 Anti-tgf-beta induction of bone cell function and bone growth
12/09/2010WO2009121519A8 Sulfated unsaturated disaccharidic chondroitin sulfate in connective tissue protection and repair
12/09/2010US20100311944 Cyclosporine analogue mixtures and their use as immunomodulating agents
12/09/2010US20100311835 Cis-9, trans-11 isomer of conjugated linoleic acid (cla) for treating inflammatory diseases
12/09/2010US20100311823 Agent for regulating bone formation
12/09/2010US20100311812 RNA INTERFERENCE MEDIATED INHIBITION OF INTERCELLULAR ADHESION MOLECULE (ICAM) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
12/09/2010US20100311787 Compounds for inflammation and immune-related uses
12/09/2010US20100311754 1,4-Disubstituted Naphthalenes as Inhibitors of P38 Map Kinase
12/09/2010US20100311749 4-benzoyl-1-substituted-piperazin-2-one derivatives as p2x7 modulators
12/09/2010US20100311744 Novel 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, cx3cr1 and p40
12/09/2010US20100311743 Azaindoles Useful as Inhibitors of Janus Kinases
12/09/2010US20100311741 Bicyclosulfonyl Acid (BCSA) Compounds and Their Use as Therapeutic Agents
12/09/2010US20100311732 Novel heterocyclic compounds
12/09/2010US20100311695 Hydroxy-bisphosphonic acid derivatives as vector targeting bone tissue
12/09/2010US20100311661 Use of compounds derived from cycloheximide for the treatment or prevention of, in particular, ischaemias and cardiopathies
12/09/2010US20100311648 Melanocortin receptor-specific peptides
12/09/2010US20100311644 Isozyme-specific antagonists of protein kinase c
12/09/2010US20100311189 Novel Receptor Nucleic Acids and Polypeptides
12/09/2010US20100311120 Human cytokine receptor
12/09/2010US20100310651 Solid pharmaceutical compositions and processes for their production
12/09/2010US20100310646 Selective exosite inhibition of papp-a activity against igfbp-4
12/09/2010US20100310626 Erythropoietin and fibronectin compositions for bone regeneration
12/09/2010US20100310625 Methods for purifying insoluble bone gelatin
12/09/2010US20100310623 Synergetic functionalized spiral-in-tubular bone scaffolds
12/09/2010US20100310565 Antibodies that bind both il-17a and il-17f and methods of using the same
12/09/2010US20100310555 Compositions with hematopoietic and immune activity
12/09/2010US20100310540 Methods of screening for compounds that modulate tafia activity, compounds, and methods of using the compounds
12/09/2010US20100310524 Compositions Suitable for Treatment of Spinal Disease, Disorder or Condition
12/09/2010US20100310515 Latency Associated Protein Construct With Aggrecanase Sensitive Cleavage Site
12/09/2010US20100310513 Bifidobacterial species
12/09/2010US20100310509 COMPOSITIONS COMPRISING MODULATORS OF SIGNAL TRANSDUCING RECEPTOR gp130 AND METHODS OF PRODUCING AND USING SAME
12/09/2010US20100310508 METHODS OF TREATMENT INVOLVING p21/CIP1
12/09/2010US20100310503 Novel compositions and methods for cancer treatment
12/09/2010US20100310501 Methods for Improving Immune Function and Methods for Prevention or Treatment of Disease in a Mammalian Subject
12/09/2010US20100310471 Antioxidant and paramagnetic heparin-nitroxide derivatives
12/09/2010US20100310464 Antibodies
12/09/2010DE102009024133A1 Bacterial nanocellulose, useful e.g. for cartilage regeneration, comprises a structure consisting of a wide-meshed phase of bacterial nanocellulose and a close-meshed phase of bacterial nanocellulose firmly connected with wide-meshed phase
12/09/2010CA2764424A1 Vaccine for mycoplasma infection
12/09/2010CA2764227A1 Formulations for the treatment of deep tissue pain
12/09/2010CA2764164A1 Immunoregulatory peptides and methods of use
12/08/2010EP2259063A2 Methods, agents, and compound screening assays for inducing differentiation of undifferentiated mammalian cells into osteoblasts
12/08/2010EP2258834A1 Human aminoacyl-tRNA synthetase polypeptides useful for the regulation of angiogenesis
12/08/2010EP2258722A2 Antibodies to fibroblast growth factor-like (FGF-like) polypeptides
12/08/2010EP2258721A1 Polyethylene glycolated lactoferrin complex and method of producing the same
12/08/2010EP2258700A1 Cycloalkylamino acid derivatives and pharmaceutical compositions thereof
12/08/2010EP2258688A1 Pyridinone derivatives for treatment of atherosclerosis
12/08/2010EP2258687A1 Nicotinamide derivates useful as P38 inhibitors
12/08/2010EP2258392A1 Method of administering therapeutic polypeptides
12/08/2010EP2258379A1 Use of platelet rich plasma composition
12/08/2010EP2258374A2 Use of maslinic acid for the treatment of diseases and the symptoms thereof by means of cox-2 inhibition
12/08/2010EP2258363A1 Compositions for treatment of cancers
12/08/2010EP2258361A1 Use of benzophenone derivative or salt thereof and tnf inhibitor in combination and pharmaceutical composition containing the derivative or salt thereof and the inhibitor
12/08/2010EP2257300A2 Formulas comprising calcium, magnesium, zinc, and vitamin d3 for the prevention and amelioration of osteoporosis
12/08/2010EP2257289A1 Pharmaceutical composition for use in the treatment or prevention of osteoarticular diseases
12/08/2010EP2257176A2 Compositions and methods for cartilage repair
12/08/2010EP2257163A2 Bone paste composition
12/08/2010EP1781290B1 Anti-inflammatory agents
12/08/2010EP1553924B1 Novel method of stabilizing diagnostic and therapeutic compounds in a cationic carrier system
12/08/2010EP1506285B1 Combinations of anti-dr5 antibodies and anti-dr4 antibodies and other therapeutic agents
12/08/2010EP1482872B1 Tissue repair matrix
12/08/2010EP1480674B1 Treatment of central nervous system damage
12/08/2010EP1471926B1 Compositions and methods for the therapeutic use of an atonal-associated sequence
12/08/2010EP1276878B1 Reversible immortalization
12/08/2010EP1093457B1 Cytokine receptor common gamma chain like
12/08/2010CN201664142U Moxa good-smelling pillow for cerebral-heart comfort
12/08/2010CN1977837B Application of monoesters of probucol for the treatment of cardiovascular and inflammatory disease
12/08/2010CN1938034B ED-71 preparation
12/08/2010CN1709409B Anti-tumor agent, beverages and foods using the same, and a process for manufacturing the anti-tumor agent
12/08/2010CN1671696B Kinase inhibitors
12/08/2010CN101910189A Monosebacate of pyrazole derivative
12/08/2010CN101910179A (e)-n-{3- [1-(8-fluoro-11h-10-oxa-1-aza-dibenzo [a,d] cycl0hepten-5ylidene)-propyl]-phenyl }-methynsulfon amide as glucocorticoid receptor modulator for the treatment of rheumatoid
12/08/2010CN101910176A Derivatives of N-phenyl-imidazo[1,2-a]pyridine-2-carboxamides, preparation thereof and therapeutic application thereof
12/08/2010CN101910175A N-phenyl-imidazo[1,2-a]pyridine-2-carboxamide compounds, preparation thereof and therapeutic application thereof
12/08/2010CN101910174A 2-benzoylimidazo[1,2-a]pyridine derivates, preparation thereof and therapeutic use thereof
12/08/2010CN101910173A Derivatives of 2-heteroaroyl-imidazol[1,2-a] pyridine, preparation thereof and therapeutic application thereof
12/08/2010CN101910172A Derivatives of n-heterocyclic-imidazo[1,2-a]pyridine-2-carboxamides, preparation thereof and therapeutic application thereof
12/08/2010CN101910153A Pyrimidines as kinase inhibitors
12/08/2010CN101910121A Bis-(sulfonylamino) derivatives in therapy 066
12/08/2010CN101906128A Estrone compound, as well as preparation method and application thereof
12/08/2010CN101906106A Novel heterocyclic compounds as HSP90-inhibitors
12/08/2010CN101906104A 2-(pyridin-2-ylamino)-pyrido[2,3-d]pyrimidin-7-ones
1 ... 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 ... 820